Augusto Villanueva Rodriguez, MD, PhD
img_Augusto Villanueva Rodriguez
ADJUNCT ASSOCIATE PROFESSOR | Medicine, Liver Diseases
Are you a patient?
Specialties
Hematology-Oncology, Gastroenterology
Research Topics
Cancer, Liver
Multi-Disciplinary Training Area
Cancer Biology [CAB]

MD, University of Santiago de Compostela

MD, Universidad Santiago de Compostela

Residence, Gastroenterology & Hepatology, University Hospital of Santiago de Compostela

PhD, Biomedical Research, University of Santiago de Compostela

MS, Research in Liver Diseases, University of Barcelona

Residency, Transplant Hepatology, University of Santiago de Compostela

Certifications

American Board of Internal Medicine

2018

Junior Faculty Award

GE Liver Gene Expression

2015

Alan Hofmann Clinical and Translational Award in Liver Diseases

American Association for the Study of Liver Diseases Foundation

2013

Rising Star Gastroenterologist, United European Gastroenterology

2008

Sheila Sherlock Fellowship, European Association for the Study of the Liver

2007

Juan Rodes Award, Asociacion Española para el Estudio del Higado

2005

Pedro Barrie de la Maza Fellow, Foundation Banco Pastor

2000

National Award for Excellence in Academic Performance, Ministry of Edication (Goverment of Spain)

Publications

Selected Publications

Current and emerging strategies for the prevention of hepatocellular carcinoma. Yee Hui Yeo, Manal Abdelmalek, Seema Khan, Cynthia A. Moylan, Luz Rodriquez, Augusto Villanueva, Ju Dong Yang. Nature Reviews Gastroenterology and Hepatology

Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma. Sarah Cappuyns, Marta Piqué-Gili, Roger Esteban-Fabró, Gino Philips, Ugne Balaseviciute, Roser Pinyol, Albert Gris-Oliver, Vincent Vandecaveye, Jordi Abril-Fornaguera, Carla Montironi, Laia Bassaganyas, Judit Peix, Marcus Zeitlhoefler, Agavni Mesropian, Júlia Huguet-Pradell, Philipp K. Haber, Igor Figueiredo, Giorgio Ioannou, Edgar Gonzalez-Kozlova, Antonio D'Alessio, Raphael Mohr, Tim Meyer, Anja Lachenmayer, Jens U. Marquardt, Helen L. Reeves, Julien Edeline, Fabian Finkelmeier, Jörg Trojan, Peter R. Galle, Friedrich Foerster, Beatriz Mínguez, Robert Montal, Sacha Gnjatic, David J. Pinato, Mathias Heikenwalder, Chris Verslype, Eric Van Cutsem, Diether Lambrechts, Augusto Villanueva, Jeroen Dekervel, Josep M. Llovet. Journal of Hepatology

The 2024 ILTS-ILCA consensus recommendations for liver transplantation for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Sudha Kodali, Laura Kulik, Antonio D'Allessio, Eleonora De Martin, Abdul Rahman Hakeem, Monica Lewinska, Stacie Lindsey, Ken Liu, Zorana Maravic, Madhukar S. Patel, David Pinato, Ashwin Rammohan, Nicole Rich, Marco Sanduzzi Zamparelli, David W. Victor, Carmen Vinaxia, Elizabeth W. Brombosz, Augusto Villanueva, Tim Meyer, Nazia Selzner, R. Mark Ghobrial, Mohamed Rela, Gonzalo Sapisochin. Liver Transplantation

View All Publications

Hepatocellular Carcinoma: New Therapies and Challenges
Update in the Clinical Management of Hepatocellular Carcinoma

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Villanueva Rodriguez during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Society of Interventional Oncology
  • Caris
  • Outcomes insights
  • Medpace, Inc.

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Atzeyo Biosensors

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.